R.PR
REGISTERED-PRINCIPAL REGISTER
03/15/2022
Back to search
Official data from USPTO
MEGABODY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MEGABODY
ST13
US500000090047069Class
1, 5, 42
Filing
90047069
Registration
6669331
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
03/15/2022
Trademark type
Word
Nice classes
1, 5, 42
Filing date
07/10/2020
Registration date
03/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/15/2022
Last transaction
03/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Gent, BE
Examiner
DUONG,ANGELA GAW
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
V. V. (pessoa física)
Representatives
Hoang-chi Truong
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Proteins for use in drug discovery and structural biologyproteinsprotein conjugatesantibodies in raw material form or as formulated reagentsall for scientificmedical and biotechnological research
Class 5
Medical and veterinary preparations for the treatment of cardiovascular diseasesallergiesimmune and inflammatory diseasesmetabolic diseasescancerdiseases of the central nervous systeminfectious diseases in humans and livestock; diagnostic preparations for medical and veterinary purposes and diagnostic materialsdiagnostic reagents and media for diagnosing cardiovascular diseasesallergiesimmune and inflammatory diseasesmetabolic diseasescancerdiseases of the central nervous systemsinfectious diseases in humans and livestock; pharmaceutical preparations for the treatment of cardiovascular diseasesallergiesimmune and inflammatory diseasesmetabolic diseasescancerdiseases of the central nervous systeminfectious diseases in humans and livestock; veterinary diagnostic reagents and diagnostic reagents for medicinal useproteins for use in drug discovery and structural biologyproteinsprotein conjugatesantibodies in raw material form or as formulated reagents; all of the aforesaid goods excluding dental impression materials
Class 42
Science and technology servicestechnical consultancy and research in the fields of drug discoverystructural biology researchbiotechnology research; science and technology servicesscientific and laboratory research in the medicalbacteriologicalbiotechnical and diagnostic fields; natural science servicesresearch in the field of structural biologyengineeringbiotechnology; medical and pharmacological research services; clinical research in the fields of cardiovascular diseasesallergiesimmune and inflammatory diseasesmetabolic diseasescancerdiseases of the central nervous systeminfectious diseases; clinical research in the fields of medical and biotechnological proceduresradiologychemotherapy and in vivo imaging; medical laboratories; conducting early evaluations in the field of new pharmaceuticals; consultancy relating to pharmaceutical research and development; drug discovery services; laboratory services relating to the production of antibodies; information technology services for the pharmaceutical and healthcare industries; all of the aforesaid services not relating to dental impression materials
Publications
History of USPTO decisions and trademark events.
29 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/28/2021
PUBO
PUBLISHED FOR OPPOSITION
12/28/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/08/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/20/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/19/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/19/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/19/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/19/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/19/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/17/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/17/2021
ALIE
ASSIGNED TO LIE
11/17/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/12/2021
EXPI
EX PARTE APPEAL-INSTITUTED
11/12/2021
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
11/12/2021
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
11/12/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/12/2021
GNFR
FINAL REFUSAL E-MAILED
05/12/2021
CNFR
FINAL REFUSAL WRITTEN
05/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/22/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/21/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/21/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/21/2020
GNRT
NON-FINAL ACTION E-MAILED
10/21/2020
CNRT
NON-FINAL ACTION WRITTEN
10/21/2020
DOCK
ASSIGNED TO EXAMINER
10/20/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2020
NWAP
NEW APPLICATION ENTERED
07/14/2020
Continuous trademark protection
Get notified about every new filing that threatens MEGABODY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.